Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms in securities class action settlements [4]

Group 1 - Canopy Growth Corporation is facing a class action lawsuit for investors who purchased securities between May 30, 2024, and February 6, 2025, with a deadline to file a lead plaintiff motion by June 3, 2025 [1] - The law firm representing the investors, Portnoy Law Firm, offers complimentary case evaluations and encourages investors to discuss their legal rights [2] - Canopy Growth reported financial results for Q3 of fiscal year 2025, which fell short of consensus estimates, with a 400 basis point decline in gross margin to 32% due to increased costs from product launches and higher indirect costs [3]

Core Points - FLUENT Corp. will report its financial results for the first quarter ended March 31, 2025, on May 29, 2025 [1] - A conference call and live audio webcast will be held to discuss the financial results and key business highlights [2] Conference Call Details - The conference call is scheduled for May 29, 2025, at 4:30 p.m. Eastern Time [3] - Participants can join via a toll-free number or an international dial-in number [3] - The call will be available for replay on FLUENT's investor relations website [4] Company Overview - FLUENT Corp. is a national cannabis consumer packaged goods company and retailer, focusing on operational excellence in cultivation, production, distribution, and retail [5] - The company operates in Florida, New York, Pennsylvania, and Texas, employing over 700 staff across 8 cultivation and manufacturing facilities and 42 retail locations [5] - FLUENT produces a variety of cannabis products under brands such as MOODS, Knack, Wandr, Bag-O, and Hyer Kind [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities during the specified class period of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities between May 30, 2024, and February 6, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing clients [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the June 3, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Canopy Growth made false and misleading statements regarding the costs associated with the launch of its Claybourne product and the impact on its gross margins [5]. - It is claimed that the company overstated the effectiveness of its cost reduction measures while downplaying financial issues, leading to investor damages when the true information became public [5].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the production of Claybourne pre-rolled joints and the launch of the Claybourne product in Canada [2]. - It is alleged that these costs, along with indirect costs related to Storz & Bickel vaporizer devices, would significantly harm the Company's gross margins and overall financial results [2]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while minimizing related issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Insights - Rubicon Organics Inc. has successfully removed all conditions precedent related to its purchase and sale agreement for the Hope Facility, a 47,500 square foot indoor cultivation facility in British Columbia [1][2][3] - The acquisition is expected to significantly enhance the company's premium production capacity and support its growth strategy, with the first harvest anticipated by the end of 2025 and revenue expected in early 2026 [2][4] Company Overview - Rubicon Organics is a licensed producer focused on cultivating and selling organic certified and premium cannabis products, with a vertically integrated structure through its subsidiary Rubicon Holdings Corp [6][7] - The company aims to achieve industry-leading profitability through its premium cannabis flower, product innovation, and brand portfolio management, which includes flagship brands such as Simply Bare™ Organic, 1964 Supply Co™, Wildflower™, and Homestead Cannabis Supply™ [6][7] Facility Details - The Hope Facility is designed with advanced cultivation technology and is expected to have an annual production capacity of up to 4,500 kilograms [4] - The facility will play a crucial role in expanding Rubicon Organics' premium product offerings to meet rising demand in the market [4][6]

Core Insights - Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and reliable medical cannabis options for patients [1][2][3] - The introduction of Good Supply reflects Tilray's commitment to enhancing patient care and empowering healthcare professionals with innovative medical cannabis solutions [2][3] - Good Supply offers a variety of cannabis strains, available in both 15g and 500g, catering to the diverse needs of patients [2][7] Company Overview - Tilray Medical is a leading player in the global medical cannabis industry, with operations in Canada, Portugal, and Germany, and is recognized for its commitment to quality and innovation [3][4] - The company has established itself as a trusted supplier of medical cannabis, with a portfolio that includes multiple brands designed to meet patient needs worldwide [4][6] - Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences [6]

Group 1 - The Cronos Group is recognized as a pioneer in the cannabis industry, known for its strong brands and strategic investment partnerships [1] - The company is experiencing continuous revenue growth and has established itself as a significant player in the market [1] - The investment approach focuses on identifying undervalued businesses with strong fundamentals, aiming to build and preserve generational wealth [1] Group 2 - The investment strategy involves screening approximately 10,000 publicly listed companies to find dominant players in resilient sectors [1] - The emphasis is on companies led by shareholder-aligned management teams that generate strong free cash flows [1]

Core Viewpoint - Blüm Holdings, Inc. is executing a strategic transaction to acquire a 100% membership interest in a holding company that has a non-controlling equity interest in Cookies Creative Consulting & Promotions, Inc., enhancing its alignment with a leading cannabis brand in the U.S. [1] Group 1: Transaction Details - The acquisition will be conducted through a newly formed wholly owned subsidiary, Blüm Acquisition Co., in exchange for 489,131 shares of Blüm common stock and a warrant for an additional 30,762 shares at an exercise price of $0.64 per share, totaling an implied value of $562,500 [2][3] - The share and warrant consideration will be subject to customary adjustments based on the verified ownership percentage of Cookies held by the seller [3] Group 2: Strategic Importance - The CEO of Blüm Holdings emphasized that this transaction is a significant step in the company's long-term strategy to increase economic exposure to major cannabis brands through strategic relationships [4] - The recent transactions are expected to provide exposure to equity value not fully visible in Blüm's public float, including its retail dispensary portfolio and Cookies-branded flagship store [4] Group 3: Future Outlook - The transaction is anticipated to close upon the completion of definitive agreements and customary closing conditions, with a target closing date set for Q3 2025 [4]